Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aryeh Fischer, MD
National Jewish Health: University of Colorado School of Medicine
Study Chair - David B. Badesch, M.D.
University of Colorado Health Sciences Center (Aurora, CO)
Study Chair - Lorinda Chung, MD
Stanford University
Study Chair - Mark Nicolls, M.D.
Stanford University
Study Chair - Robyn Domsic, MD
University of Pittsburgh: Division of Rheumatology and Clinical Immunology
Study Chair - Thomas A. Medsger, Jr., M.D.
University of Pittsburgh
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford Health Care
Stanford, California, United States
- University of Colorado Health Sciences Center
Aurora, Colorado, United States
- University of Iowa
Iowa City, Iowa, United States
- Johns Hopkins University, Pulmonary and Critical Care Medicine
Baltimore, Maryland, United States
- Boston University Medical Center
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of Minnesota Health Clinics and Surgery Center
Minneapolis, Minnesota, United States
- Columbia University Medical Center
New York, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- University of North Carolina at Chapel Hill: Unc Hospitals
Chapel Hill, North Carolina, United States
- Ohio State University
Columbus, Ohio, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas Southwestern Medical Center-William P. Clements University Hospital
Dallas, Texas, United States
- University of Texas: Memorial Herman Hospital
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Jun 2011
- Primary completion
- 5 Jun 2018
- Completion
- 15 Dec 2019
- Last update posted
- 21 Feb 2023
- Registered enrollment
- 57
- Registry id
- NCT01086540
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.